Because of the multifaceted effects on tumor vessels, the VEGF-A:VEGFR2 signaling axis has been pursued as a therapeutic target in adult solid tumors with approvals across a number of tumor histologies [11–13]. The gene discussed is VEGFA; the disease is neoplasm.